Avaleht › Krooniline lümfotsütaarne leukeemia › New Jersey
Krooniline lümfotsütaarne leukeemia kliinilised uuringud osariigis New Jersey
13 uuringut haiguse Krooniline lümfotsütaarne leukeemia jaoks otsivad osalejaid osariigis New Jersey.
Linnad osariigis New Jersey
Ametlik uuringutekst (inglise keeles)
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
- Jefferson Cherry Hill Hospital, Cherry Hill
- Sidney Kimmel Cancer Center Washington Township, Sewell
VärbamineFaas 3
Vanused 65 ja vanemad · Kõik sood · Uuendatud 2. okt 2026 · NCT07321652Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Englewood Hospital and Medical Center, Englewood
- Hackettstown Medical Center, Hackettstown
- Morristown Medical Center, Morristown
- ja veel 6
VärbamineVaatlusuuringTerved vabatahtlikud oodatud
Vanused 40–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT05334069A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
- Research Site, Hackensack
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT06542250Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Cooper Hospital University Medical Center, Camden
- Jersey City Medical Center, Jersey City
- ja veel 7
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT04269902A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
- Sidney Kimmel Comprehensive Cancer Center Washington Twp, Sewell
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06943872A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Titan Health Partners Llc Dba Astera Cancer Care, East Brunswick
- John Theurer Cancer Center Hackensack University Medical Center, Hackensack
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT06973187A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0016), Hackensack
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 24. sept 2026 · NCT06136559Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Hackensack Meridian Health, Hackensack
- Carol G Simon Cancer Center, Morristown
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 21. sept 2026 · NCT07648264A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Research Site, Hackensack
- Research Site, New Brunswick
VärbamineFaas 1/2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT06564038Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
- Atlantic Health, Morristown
VärbamineFaas 1/2
Vanused 12 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT04588922A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
- Summit Medical Group, Florham Park
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 12. juuni 2026 · NCT07271667Study of SGR-1505 in Mature B-Cell Neoplasms
- Regional Cancer Care Associates, Hackensack
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. veebr 2026 · NCT05544019Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
- Regional Cancer Care Associates /ID# 244620, Hackensack
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. veebr 2026 · NCT04895436Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.